BRAF and neoplasm: If an upregulated MAPK pathway is in fact the most important mechanism that drives tumor proliferation in melanomas carrying the BRAFV600E mutation, the high selectivity and potency of these new agents should provide more insight into the role of BRAF as a critical therapeutic target in melanoma.